Correcting Overall Survival for the Impact of Crossover Via a Rank-Preserving Structural Failure Time (RPSFT) Model in the RECORD-1 Trial of Everolimus in Metastatic Renal-Cell Carcinoma. - Korhonen, P.; Zuber, E.; Branson, M.; Hollaender, N.; Yateman, N.; Katiskalahti, T.; Lebwohl, D.; Haas, T. (Journal of Biopharmaceutical Statistics, 2012)